PFK-23294-18127
2 vaccinations
2 coded responses
17 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 450 / OH
- Registered
- 2022-10-13
- Relationship
- Child or adolescent in my care
- Guardian
- JMD-27253-31553
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-10-13
Registered in v-safe
-
2022-10-13
Dose 1 — Pfizer-BioNTech
- 2022-10-14
- 2022-10-15
- 2022-10-16
- 2022-10-17
- 2022-10-19
- 2022-10-27
-
2022-11-03
Dose 2 — Pfizer-BioNTech
- 2022-11-05
- 2022-11-06
- 2022-11-07
- 2022-11-08
- 2022-11-10
- 2022-11-17
- 2022-11-24
- 2022-12-02
- 2022-12-10
-
2023-02-02
Survey response — 3 months, dose 2, under 3MedDRA: Rhinorrhoea — Feeling: FairMedDRA releases: 2024-11
-
2023-05-04
Survey response — 6 months, dose 2, under 3MedDRA: Rhinorrhoea — Feeling: GoodMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-10-13 | Pfizer-BioNTech | No |
| 2 | 2022-11-03 | Pfizer-BioNTech | No |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release